ensuring broader access to effective treatments. Growing awareness campaigns, such as those conducted by the Sjogren Syndrome Foundation of America, contribute significantly to the market’s expansion.
the need to address oral side effects of cancer treatment is critical. This webinar will educate dental professionals on managing 'Chemo Mouth' – a set of symptoms including mucositis, dry mouth, ...
AbbVie (NYSE: ABBV) today announced that its two Phase 2 EMPOWER trials investigating emraclidine as a once-daily, oral monotherapy treatment for adults with schizophrenia who are experiencing an ...